Human IL-23 / IL-23R Inhibitor Screening Kit (TR-FRET)

Customer Reviews
Cat. No. / Size
Price
Qty
FRT-P010-100tests
$520.00
FRT-P010-500tests
$1050.00
ETA of in-stock products:2 business days

Product Details

  • FAB

    1. Simple and fast operation - No complicated washing steps, significantly reducing time.
    2. High batch consistency - Strict control over raw materials and finished product quality, ensuring a stable supply.
    3. Accurate and reliable results - High sensitivity with minimal matrix effects.
    4. High throughput capability - Support multiple product specifications, ideal for high-throughput screening.
    5. Fast completion - Results in just 1 hour.
  • Product Specifications

    Assay Type
    Competition-TR-FRET
    Reactivity
    Human
    Regulatory Status
    RUO
    Assay Time
    1 hr
    Sample volume
    10 μL

  • Product Overview

    The Human IL-23 / IL-23R Inhibitor Screening Kit (TR-FRET) is based on a homogeneous (no wash) competition TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer) to screening for inhibitors of human IL-23 binding to human IL-23R within 0.5-1 hours. It can also be used as a universal detection tool to identify the ability of human IL-23 to bind to human IL-23R.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Materials Provided

    ID
    Components
    Size
    FRTP010-C01
    Human IL-23 alpha&IL-12 beta Heterodimer Protein Europium-chelate
    100 tests/500 tests
    FRTP010-C02
    FA Labeled Human IL-23R
    100 tests/500 tests
    FRTP010-C03
    Anti-IL23A Neutralizing Antibody
    30 μg/100 tests 150 μg/500 tests
    DB-04
    TR-FRET Sample Dilution Buffer, pH7.4
    50 mL/100 tests & 500 tests
    DB-05
    TR-FRET Detection Buffer, pH7.4
    50 mL/100 tests & 500 tests

  • Assay Principles

    This Human IL-23 / IL-23R Inhibitor Screening Kit (TR-FRET) is based on TR-FRET technology (Time-Resolved Fluorescence Resonance Energy Transfer). Use a mixture of biotinylated IL-23 alpha&IL-12 beta and Europium-chelate labeled streptavidin as the donor and FA labeled human IL-23 R as the acceptor.

    — In the absence of inhibitors for human IL-23 R binding to IL-23 alpha&IL-12 beta, the donor and acceptor are in close proximity due to the binding of human IL-23 R and IL-23 alpha&IL-12 beta. Upon excitation with a specific light source, the donor emits a 620 nm signal, which is absorbed by the acceptor, resulting in a 665 nm emission.

    — In the presence of inhibitors that block the binding of human IL-23 R to IL-23 alpha&IL-12 beta,the donor-acceptor interaction is disrupted, preventing FRET from occurring.

    Assay Principles
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-TR-FRET 

    Please refer to DS document for the assay protocol.

     IL-23 TR-FRET

    Inhibition of Europium-chelate labeled Human IL-23 alpha&IL-12 beta Heterodimer Protein : FA Labeled Human IL-23R binding by Anti-IL23A Neutralizing Antibody
    Premix serial dilutions of Anti-IL23A Neutralizing Antibody (1:2 serial dilution, from 10 μg/mL to 0.01 μg/mL (66.67-0.07 nM)) and Human IL-23 alpha&IL-12 beta Heterodimer Protein Europium-chelate. Then add FA Labeled Human IL-23R and incubate at room temperature (20℃-25℃) for 1 hours. Detection was performed with IC50 of 1.737nM. The assay was performed according to the above-described Datasheet (QC tested).

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews